Funding
Funding not disclosed
Founders
Product
Problem
Current methods for continuous blood analysis are invasive, requiring frequent blood draws or the use of implanted sensors. This limits the ability to gather real-time, comprehensive physiological data for proactive health management.
Solution
RayLife is developing a novel biowearable device designed for continuous, noninvasive blood analysis. The platform integrates advanced optical sensing technology with proprietary chip architecture and AI algorithms to derive key blood analytes. This approach enables the continuous monitoring of physiological markers, providing users with personalized health insights and facilitating early detection of health trends. The device aims to offer a convenient and data-rich alternative to traditional blood testing methods.
Target Audience
The primary target audience includes individuals seeking proactive health management and continuous physiological monitoring, as well as healthcare providers and researchers interested in noninvasive diagnostic tools.
Features
- Noninvasive optical sensing technology for continuous blood analyte measurement.
- Integrated microchip architecture for on-device data processing and analysis.
- AI-driven algorithms for interpreting sensor data and generating health insights.
- Wearable form factor for persistent, real-time physiological monitoring.
- Focus on deriving multiple blood analytes without requiring fluid extraction.